Ignite Creation Date:
2025-12-24 @ 1:00 PM
Ignite Modification Date:
2025-12-29 @ 9:38 PM
Study NCT ID:
NCT00014261
Status:
COMPLETED
Last Update Posted:
2018-03-30
First Post:
2001-04-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors
Sponsor:
Dartmouth-Hitchcock Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2000-10
Start Date Type:
ACTUAL
Primary Completion Date:
2002-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2002-11
Completion Date Type:
ACTUAL
First Submit Date:
2001-04-10
First Submit QC Date:
None
Study First Post Date:
2003-07-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-28
Last Update Post Date:
2018-03-30
Last Update Post Date Type:
ACTUAL